Method for producing l-threonine by immobilized fermentation using specific binding of recombinant escherichia coli having adhesin protein displayed on its surface to modified material
By constructing an immobilized fermentation method combining recombinant Escherichia coli with surface-displaying adhesin proteins and modified fiber materials, the problem of non-reusable cells in L-threonine fermentation was solved, achieving efficient L-threonine production, reducing costs and shortening the fermentation cycle.
Patent Information
- Application Number
- PCT/CN2026/080574
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-14
- Filing Date
- 2026-02-28
- Publication Date
- 2026-11-19
AI Technical Summary
In existing technologies, cells cannot be reused during L-threonine fermentation, resulting in high operating costs, reduced cell viability, and long fermentation cycles, making it difficult to meet industrialization needs.
Recombinant Escherichia coli ΔycgF was used to anchor the adhesin protein FimH on the surface for display, and it specifically bound to the modified fiber material to produce L-threonine through immobilized fermentation.
It shortens the fermentation cycle, improves the metabolic activity of cells, enables the recycling of cells, reduces production costs, and provides a more suitable industrial fermentation method.
Smart Images

Figure PCTCN2026080574-FTAPPB-I100001 
Figure PCTCN2026080574-FTAPPB-I100002 
Figure PCTCN2026080574-FTAPPB-I100003
Abstract
Description
A method for producing L-threonine by specifically binding and immobilizing recombinant Escherichia coli with a modified material using surface-displayed adhesin proteins. Technical Field
[0001] This invention relates to the field of microbial fermentation for L-threonine production, and more specifically to a method for producing L-threonine by specifically binding and immobilizing recombinant Escherichia coli with a modified material using a surface-displayed adhesin protein. Background Technology
[0002] L-Threonine is an essential amino acid that the human body cannot synthesize and must obtain through diet. It primarily participates in protein synthesis, maintains muscle and tissue health, and supports immune system function (such as antibody production). Simultaneously, it helps form a mucus barrier in the gut to protect the digestive system, promotes liver fat metabolism and detoxification, and is a neurotransmitter precursor, indirectly supporting brain function. L-Threonine plays a crucial role in health management and production practices, with significant applications in multiple fields: it is used in pharmaceuticals and nutritional supplements to help improve protein synthesis, repair tissues, enhance immunity, and maintain gut health; in animal husbandry, it is a key additive in animal feed, promoting growth, enhancing immunity, and improving meat quality; furthermore, it is fortified in specific functional foods (such as protein powder or special diets) in the food industry to meet the body's needs for essential amino acids. Currently, with the widespread application of L-Threonine in the food, chemical, and pharmaceutical industries, the demand for L-Threonine is increasing dramatically.
[0003] In biofilm immobilized fermentation, cells communicate with each other, coordinate gene expression, and achieve physiological synergy, thereby improving the metabolic activity of the cells. This not only increases substrate and product tolerance but also ensures cell viability, shortens the fermentation cycle, and improves product quality. Therefore, biofilm immobilization technology has broad prospects for industrial applications. Pili are the cellular motility organs of Gram-negative bacteria. Escherichia coli has many types of pili, among which type I pili are important adhesion organelles, including nine genes from fimA to fimH. The fimH gene encodes the type I pili adhesin protein FimH, which is responsible for adhesion to abiotic surfaces and is a key gene for E. coli biofilm formation.
[0004] Currently, microbial fermentation for L-threonine production is widely used in industrial-scale L-threonine production. However, L-threonine production still suffers from the problem of cells not being reusable after a single batch of free fermentation. Batch fermentation and single-use of cells increase operating costs and reduce productivity. Furthermore, free cells dispersed in the fermentation medium are subjected to stress conditions (such as shear force) during aerobic fermentation, leading to reduced cell viability. Therefore, developing an industrial-scale method for L-threonine production that can increase L-threonine yield while shortening the fermentation cycle, enhancing cell metabolic activity, enabling cell recyclability, and saving costs is of significant practical importance. Summary of the Invention
[0005] The technical problem to be solved by the present invention is to provide a recombinant Escherichia coli that addresses the shortcomings of the prior art.
[0006] Another technical problem to be solved by the present invention is to provide the application of the recombinant Escherichia coli in the immobilized fermentation production of L-threonine.
[0007] The final technical problem to be solved by this invention is to provide a method for producing L-threonine by specifically binding recombinant Escherichia coli with modified materials and immobilizing them through fermentation.
[0008] To solve the above-mentioned technical problems, the technical solution provided by the present invention is as follows:
[0009] A recombinant Escherichia coli strain was constructed by using Escherichia coli ΔycgF as the starting strain and anchoring the adhesin protein FimH with an anchoring protein to obtain a recombinant Escherichia coli strain displaying the adhesin protein on its surface.
[0010] The Escherichia coli ΔycgF, also known as Escherichia coli W1688-bluF, has detailed information disclosed in patent CN114317389A.
[0011] The anchoring protein includes any one of LPP-OmpA, Ag43, and eCPX.
[0012] Preferably, the anchoring protein includes either LPP-OmpA or eCPX; more preferably, the anchoring protein is LPP-OmpA.
[0013] The nucleotide sequence of the adhesin protein FimH is shown in SEQ ID NO:4; the nucleotide sequence of the anchoring protein Lpp-OmpA is shown in SEQ ID NO:1; the nucleotide sequence of the anchoring protein Ag43 is shown in SEQ ID NO:2; and the nucleotide sequence of the anchoring protein eCPX is shown in SEQ ID NO:3.
[0014] The anchoring protein anchors the adhesin protein FimH to form a fusion protein, and the fusion protein is expressed by a promoter.
[0015] Specifically, the promoter is any one of the nucleotide sequences such as SEQ ID NO:5 to 9.
[0016] In some embodiments of the present invention, the promoters of the nucleotide sequences shown in SEQ ID NO:5-9 are promoter 100, promoter 101, promoter 105, promoter 106, and promoter 119, respectively.
[0017] Preferably, the promoter is promoter 101, promoter 105, promoter 106, or promoter 119; more preferably, the promoter is promoter 106 (i.e., the nucleotide sequence is as shown in SEQ ID NO:8).
[0018] Preferably, the fusion protein is LPP-OmpA-fimH, and its nucleotide sequence is shown in SEQ ID NO:10.
[0019] The application of the recombinant Escherichia coli in the immobilized fermentation production of L-threonine is also within the scope of protection of this invention.
[0020] A method for producing L-threonine by immobilizing recombinant Escherichia coli with modified materials through specific binding is also within the scope of protection of this invention.
[0021] Specifically, L-threonine is produced by immobilizing and fermenting recombinant Escherichia coli using modified fiber materials as carriers.
[0022] The fiber material includes any one or a combination of several of the following: cotton fiber, flax, nylon, polyester, polypropylene fiber, and polyethylene fiber.
[0023] Preferably, the fiber material is cotton fiber.
[0024] The modified fiber material is obtained by reacting the fiber material in a modified solution.
[0025] Specifically, the modified solution has a solute of any one or a combination of several of polyethyleneimine, dopamine, and mannose, and its solvent is water.
[0026] Specifically, the mass ratio of dopamine:polyvinylimine:mannose is 0-1:0-2:0-40, and the three components are not simultaneously 0. The specific values for 0-1 are 0 or 1; the specific values for 0-2 are 0, 0.5, 1, 1.5, or 2; and the specific values for 0-40 are 0, 2, 4, 6, 8, 10, 20, 30, or 40.
[0027] Preferably, in Erlenmeyer flask No. 1 and Erlenmeyer flask No. 5, the mass ratio of dopamine, polyethyleneimine and mannose is 1:0.5 to 2:2 to 40, and the order of solvent addition is different between the two.
[0028] Specifically, in Erlenmeyer flask No. 1, polyethyleneimine is added first, then mannose, and finally dopamine; in Erlenmeyer flask No. 5, dopamine, polyethyleneimine, and mannose are added simultaneously.
[0029] In some embodiments of the present invention, the mass ratio of dopamine, polyethyleneimine, and mannose in Erlenmeyer flask No. 1 and Erlenmeyer flask No. 5 is 1:1:10.
[0030] Preferably, in the No. 2 Erlenmeyer flask, the mass ratio of dopamine, polyethyleneimine, and mannose is 0:1:2 to 20.
[0031] In some embodiments of the present invention, the mass ratio of dopamine, polyethyleneimine, and mannose in the No. 2 Erlenmeyer flask is 0:1:10.
[0032] Preferably, in the No. 3 Erlenmeyer flask, the mass ratio of dopamine, polyethyleneimine, and mannose is 1:0.5 to 2:0.
[0033] In some embodiments of the present invention, the mass ratio of dopamine, polyethyleneimine, and mannose in the No. 3 Erlenmeyer flask is 1:1:0.
[0034] Preferably, in the No. 4 Erlenmeyer flask, the mass ratio of dopamine, polyethyleneimine, and mannose is 1:0:2 to 40.
[0035] In some embodiments of the present invention, the mass ratio of dopamine, polyethyleneimine, and mannose in the No. 4 Erlenmeyer flask is 1:0:10.
[0036] The fiber material is added at a rate of 10–40 g / L; preferably, it is added at a rate of 20–30 g / L.
[0037] The reaction conditions are as follows: reaction time of 0.5 to 30 hours, reaction temperature of 20 to 80°C, rotation speed of 80 to 200 rpm, and reaction pH of 3.5 to 10.5.
[0038] The inoculation amount of the seed liquid of the recombinant Escherichia coli is 2-8% v / v.
[0039] In some embodiments of the present invention, the inoculation amount of the seed liquid is 4% v / v.
[0040] The immobilized fermentation medium comprises: 20–40 g / L glucose, 1–3 g / L yeast extract, 0.5–2 g / L KH₂PO₄, 20–30 g / L (NH₄)₂SO₄, 0.5–1 g / L MgSO₄·7H₂O, 0.01–0.05 g / L MnSO₄·5H₂O, 0.01–0.04 g / L FeSO₄·7H₂O, 0.001–0.003 g / L vitamin B1, and 10–30 g / L CaCO₃.
[0041] Specifically, the glucose concentration can be taken as follows: 20g / L, 25g / L, 30g / L, 35g / L or 40g / L.
[0042] Specifically, the yeast powder concentration can be taken as follows: 1g / L, 1.5g / L, 2g / L, 2.5g / L or 3g / L.
[0043] Specifically, the KH2PO4 concentration can be taken as follows: 0.5 g / L, 1 g / L, 1.5 g / L or 2 g / L.
[0044] Specifically, the concentration of (NH4)2SO4 can be taken as follows: 20 g / L, 22 g / L, 24 g / L, 26 g / L, 28 g / L or 30 g / L.
[0045] Specifically, the concentration of MgSO4·7H2O can be taken as follows: 0.5 g / L, 0.6 g / L, 0.7 g / L, 0.8 g / L, 0.9 g / L or 1.0 g / L.
[0046] Specifically, the concentration of MnSO4·5H2O can be taken as follows: 0.01 g / L, 0.02 g / L, 0.03 g / L, 0.04 g / L or 0.05 g / L.
[0047] Specifically, the concentration of FeSO4·7H2O can be taken as follows: 0.01 g / L, 0.02 g / L, 0.03 g / L or 0.04 g / L.
[0048] Specifically, the vitamin B1 concentration can be taken as follows: 0.001 g / L, 0.002 g / L or 0.003 g / L.
[0049] Specifically, the CaCO3 concentration can be taken as follows: 10 g / L, 15 g / L, 20 g / L, 25 g / L or 30 g / L.
[0050] In some embodiments of the present invention, the immobilized fermentation is carried out using a fermentation medium containing: 30 g / L glucose, 2 g / L yeast extract, 1 g / L KH2PO4, 22 g / L (NH4)2SO4, 0.8 g / L MgSO4·7H2O, 0.02 g / L MnSO4·5H2O, 0.02 g / L FeSO4·7H2O, 0.002 g / L vitamin B1, and 30 g / L CaCO3.
[0051] The immobilized fermentation is carried out under the following conditions: constant temperature fermentation at 30-44℃ and 150-250rpm. When the glucose content in the fermentation broth is lower than 1g / L, the first batch of fermentation is terminated, 60%-90% of the fermentation broth is discharged, and an equal volume of fermentation medium is added to start the second batch of fermentation. The immobilized fermentation process of discharging 60%-90% of the fermentation broth and adding an equal volume of fermentation medium is repeated for 5-8 batches.
[0052] In some embodiments of the present invention, the immobilized fermentation was performed for seven consecutive batches. Beneficial effects:
[0053] (1) Based on the ΔycgF strain, this invention utilizes anchoring protein to anchor the adhesin protein FimH to construct a recombinant Escherichia coli with the fimH gene displayed on its surface, which promotes the formation of biofilm in the recombinant strain; furthermore, by modifying the modified fiber material carrier with mannose, specific adsorption between Escherichia coli and the carrier is achieved, which promotes the binding between the bacteria and the material and promotes the fermentation of L-threonine by Escherichia coli.
[0054] (2) This invention is the first to combine surface display with material modification system to produce amino acids based on biofilm immobilization fermentation. It shortens the fermentation cycle, makes the cells have higher metabolic activity, realizes the recycling of cells, and saves costs. It provides a more suitable fermentation method for industrial fermentation to produce L-threonine. Attached Figure Description
[0055] The present invention will be further described in detail below with reference to the accompanying drawings, and the advantages of the present invention in the above and / or other aspects will become clearer.
[0056] Figure 1 shows the plasmid map of the recombinant plasmid ptrc99a-LPP-OmpA-fimH.
[0057] Figure 2 shows the electrophoresis diagram of the extracted plasmid ptrc99a. Lane 1 contains the ptrc99a plasmid, which is 4176 bp. Lane 2 contains the ptrc99a plasmid after enzyme digestion, and lane 3 contains the 10000 DNA marker.
[0058] Figure 3 shows the electrophoresis diagram of the recombinant plasmid ptrc99a-LPP-OmpA-fimH. Lane 1 contains the recombinant plasmid ptrc99a-LPP-OmpA-fimH, which is 5477 bp, and lane 2 contains the 10000 DNA marker.
[0059] Figure 4 shows the electrophoresis diagram of colony PCR verification. Lane 1 is the 2000 DNA marker, lane 2 is the colony PCR band verification of ptrc99a-LPP-OmpA-fimH, and lane 3 is the blank control of the original strain colony PCR.
[0060] Figure 5 shows the growth curves and SDS-PAGE images of each modified strain. In Figure 5, A represents the strain growth curve; B represents the SDS-PAGE image. The markers used in the three images from left to right are Low Marker, Low Marker, and High Marker, respectively.
[0061] Figure 6 shows the flow cytometry results used to detect whether fimH was successfully displayed on the cell surface and the display efficiency in each modified strain.
[0062] Figure 7 shows the results of the crystal violet staining experiment to investigate the biofilm formation ability.
[0063] Figure 8 shows fiber materials after different glycosylation modifications.
[0064] Figure 9 shows the FTIR spectra of the unmodified cotton fiber carrier and the modified cotton fiber carrier.
[0065] Figure 10 shows an observation using a laser scanning confocal microscope (CLSM).
[0066] Figure 11 shows the trend of various parameters during immobilized continuous fermentation. The upper figure shows the trend of various parameters during immobilized continuous fermentation of strain ΔycgF using unmodified cotton fiber carriers; the lower figure shows the trend of various parameters during immobilized continuous fermentation of strain ΔycgF+LPP-OmpA-fimH using modified cotton fiber carriers.
[0067] Figure 12 shows a scanning electron microscope (SEM) image of the carrier.
[0068] Figure 13 shows the OD determination of the supernatant after elution with different buffer solutions. Detailed Implementation
[0069] The present invention will be further described in detail below with reference to specific embodiments, and the advantages of the present invention in the above and / or other aspects will become clearer.
[0070] Unless otherwise specified, the experimental methods described in the following examples are conventional methods; the reagents and materials described are commercially available unless otherwise specified.
[0071] In the following embodiments, the Escherichia coli ΔycgF strain, also known as the W1688-bluF strain, has detailed information disclosed in patent CN114317389A.
[0072] This patent was approved by the Jiangsu Provincial Postgraduate Practice and Innovation Program in 2025, with project number SJCX25_0583.
[0073] Example 1: Molecular modification of the target strain
[0074] Promoters with laboratory numbers 100, 101, 105, 106, and 119 were selected for screening, and LPP-OmpA / Ag43 / eCPX was selected for anchoring protein screening to construct different modified strains of anchoring adhesin protein FimH.
[0075] The nucleotide sequence of Lpp-OmpA is shown in SEQ ID NO:1, the nucleotide sequence of Ag43 is shown in SEQ ID NO:2, the nucleotide sequence of eCPX is shown in SEQ ID NO:3, the nucleotide sequence of the fimH gene of the adhesin protein FimH is shown in SEQ ID NO:4, and the nucleotide sequences of promoters 100, 101, 105, 106, and 119 are shown in SEQ ID NO:5 to 9 respectively.
[0076] Take the modified strain ΔycgF+LPP-OmpA-fimH (also known as +p106-LPP) as an example.
[0077] 1. Synthesize the target gene
[0078] Using Lpp-OmpA, an intercalated protein of lipoprotein Lpp and outer membrane protein OmpA, as the anchoring protein, and anchoring the type I fimbrial adhesin protein fimH, a fragment containing promoter 106, was prepared, and the linkage is shown in Figure 1. The above fragment LPP-OmpA-fimH was synthesized by Nanjing Genscript Biotech Co., Ltd., and its nucleotide sequence is shown in SEQ ID NO:10.
[0079] 2. Construction of recombinant plasmids
[0080] 2.1 Plasmid extraction
[0081] E. coli DH5α glycerol bacteria (containing plasmid ptrc99a) were inoculated into LB liquid containing 50 μg / mL ampicillin and cultured at 37°C for 12 hours. The cultured cells were then collected in 1.5 mL centrifuge tubes and centrifuged at 10,000 rpm for 2 min, and the supernatant was discarded. The plasmid ptrc99a was then extracted using a plasmid extraction kit (catalog number 9760) from Takara (Figure 2).
[0082] 2.2 Linearization of the carrier
[0083] To ligate LPP-OmpA-fimH into plasmid ptrc99a, the plasmid vector needs to be digested with enzymes. The digestion reaction system (20 μL) consisted of: 2 μL 0.1% BSA, 2 μL 1*M buffer, 1 μL NcoI enzyme, 1 μL HindIII enzyme, 10 μL plasmid ptrc99a, and 4 μL sterile water. The digestion reaction was carried out at 37°C for 2 h. After digestion, the linearized vector ptrc99a was obtained by gel extraction and used in subsequent experiments.
[0084] 2.3 Construction of recombinant plasmid ptrc99a-LPP-OmpA-fimH
[0085] The LPP-OmpA-fimH fragment synthesized in step 1 was combined with the purified linear vector ptrc99a according to Vazyme's instructions. Following the steps in the instructions of the II one-step cloning kit, the recombinant plasmid ptrc99a-LPP-OmpA-fimH was obtained. The plasmid map of the recombinant plasmid ptrc99a-LPP-OmpA-fimH is shown in Figure 1.
[0086] The one-step cloning reaction system is shown in Table 1. After bathing in a water bath at 37°C for 30 minutes, it is immediately placed in an ice bath for 5 minutes and then stored at -20°C.
[0087] Table 1 One-step cloning reaction system
[0088] 3. Transformation and screening of recombinant plasmids
[0089] Remove E. coli DH5α competent cells and thaw them on ice until liquid. Add competent cells and plasmids at a ratio of 10:1 to a pre-chilled centrifuge tube. Incubate on ice for 30 min, then heat shock in a 42°C water bath for 90 seconds. Cool in an ice box for 3 min, add 1 mL LB, and incubate on a shaker at 37°C and 200 rpm for 1 hour. Centrifuge to remove most of the supernatant, resuspend the bacterial culture, and plate it on ampicillin-resistant plates.
[0090] A single spot was picked from the plate and inoculated into a shaker tube (50 μg / mL ampicillin). The tube was incubated overnight at 37°C, and then the recombinant plasmid ptrc99a-LPP-OmpA-fimH was extracted. Sequencing primers were designed as shown in Table 2. As shown in Figure 3, the recombinant plasmid ptrc99a-LPP-OmpA-fimH was successfully constructed.
[0091] Table 2. Experimental primer sequences used for sequencing
[0092] After successful sequencing verification, the constructed plasmid was transformed into E. coli ΔycgF competent cells using the same transformation method. Single colonies were picked for colony PCR verification, using primers as shown in Table 2. As shown in Figure 4, the colony PCR bands were correct, indicating successful construction of the modified strain, namely, the modified strain ΔycgF+LPP-OmpA-fimH (also known as +p106-LPP).
[0093] Following the construction method of the target strain ΔycgF+LPP-OmpA-fimH (also known as +p106-LPP), different modified E. coli strains were constructed by replacing different promoters and anchoring proteins: +p100-LPP, +p101-LPP, +p105-LPP, +p100-eCPX, +p101-eCPX, +p105-eCPX, +p106-eCPX, +p119-eCPX, +p100-Ag43, +p101-Ag43, +p105-Ag43, +p106-Ag43, and +p119-Ag43. Among these, LPP-OmpA is located at the N-terminus of fimH, while eCPX and Ag43 are located at the C-terminus of fimH.
[0094] Example 2: Characterization of the adhesin protein fimH of type I fimbriae
[0095] 1. Growth curve
[0096] Fifteen modified *E. coli* strains, namely ΔycgF, +p100-LPP, +p101-LPP, +p105-LPP, +p106-LPP, +p100-eCPX, +p101-eCPX, +p105-eCPX, +p106-eCPX, +p119-eCPX, +p100-Ag43, +p101-Ag43, +p105-Ag43, +p106-Ag43, and +p119-Ag43, were cultured overnight in liquid LB medium. Except for strain ΔycgF, the other modified strains were supplemented with 100 mg / mL Amp antibiotic. The OD values of each overnight culture were... 600 After being diluted to a concentration of 1, the samples were inoculated into fresh LB medium and incubated at 37°C and 200 rpm for 14 hours. The OD values were measured every 2 hours.600 .
[0097] As shown in Figure 5A, the growth trend of the modified strain is basically the same as that of WT(ΔycgF). The strain modification did not change the growth status of the strain. However, the strain with p100-LPP added to ΔycgF showed a significant change in its growth status.
[0098] 2. SDS-PAGE
[0099] Cells from different modified *E. coli* strains were centrifuged at 8000 rpm for 10 min at 4°C. The resulting cell pellet was resuspended in 5 mL of PBS and centrifuged again at 8000 rpm for 10 min at 4°C. The supernatant was discarded, and the cell pellet was resuspended in 5 mL of PBS. The resuspended cell suspension was then disrupted using a cell disruptor at 30% power, with a 3-second over-discharge and 7-second pause, for a total of 10 min. Throughout the disruption process, the cells were kept in an ice-water bath to prevent protease denaturation and inactivation. After disruption, the suspension was centrifuged at 12000 rpm for 10 min at 4°C, and the pellet was collected as a sample.
[0100] The preparation process of SDS-PAGE denaturing acrylamide gel is as follows: SDS-PAGE denaturing acrylamide gel was prepared using a Sangon Biotech kit (catalog number: C631100). Based on the protein size distribution according to this invention, a separating gel of 6%–10% was selected. The separating gel composition is shown in Table 3. The prepared separating gel was added between the fixed glass plates and allowed to solidify. After solidification, a stacking gel was prepared according to the composition in Table 4. The prepared stacking gel was added between the fixed glass plates containing the separating gel, and a comb was inserted. The gel was allowed to solidify. The running buffer was prepared using Sangon Biotech (catalog number: C520001-0500) 10×Tris-Glycine SDS PAGE Running Buffer.
[0101] Table 3. Separating Gel Components (mL)
[0102] Table 4. Components of the stacking gel (mL)
[0103] The relative protein concentration was determined by SDS-PAGE denaturing acrylamide gel electrophoresis. The specific steps are as follows: 9 μL of sample was mixed with 3 μL of 4× loading buffer and placed in a 95℃ water bath for 10 min. 10 μL of the sample was added to the gel wells. 10 μL of the same marker was also added. Premixed Protein Marker (Broad or Low) (Takara Code No. 3597A and No. 3595A, concentration 0.5 μg / μL) was used at 150V for 50 min. After electrophoresis, remove the gel and place it in a glass dish containing 1% Coomassie Brilliant Blue stain (formula: 1g Coomassie Brilliant Blue R-250, 450mL ethanol, 100mL glacial acetic acid, dissolved in ultrapure water and brought to a final volume of 1L) for staining for 2 hours at 60rpm / min. After staining, replace the elution buffer (formula: 100mL ethanol, 100mL glacial acetic acid, 800mL ultrapure water) and elute three times until the gel is transparent and the blue background is gone. Then place the gel block in a gel imaging system for photography.
[0104] The results showed (Figure 5B) that a series of strains (+p100-LPP, +p101-LPP, +p105-LPP, +p106-LPP, +p100-eCPX, +p101-eCPX, +p105-eCPX, +p106-eCPX, +p119-eCPX) using LPP-OmpA and eCPX as anchor proteins were able to express the fusion protein on the cell wall, while Ag43 was unable to successfully express the fusion protein.
[0105] 3. Flow cytometer
[0106] To verify whether fimH was successfully displayed on the surface of *E. coli* cells and the display efficiency, this embodiment further performed flow cytometry analysis to observe the display efficiency of the strain. The specific procedure is as follows: 1 mL of cultured cells was collected by centrifugation, and the cells were washed three times with PBS (pH=7.4), followed by resuspension in PBS (pH=7.4) containing 2% BSA. Then, 200–1000 μL of the cell suspension was added to 200 μL of HIS-tagged mouse monoclonal antibody (His Tag Mouse Monoclonal Antibody, 1:100 dilution), and incubated at 37°C for 30 min–2 h, followed by washing with PBS. Sample detection was performed on a flow cytometer with FITC excitation at 488 nm, and the distribution of fluorescence signals was recorded.
[0107] As shown in Figure 6, the modified strains +p100-LPP and +p106-LPP exhibited the highest display efficiencies, at 71.22% and 60.68%, respectively. However, the growth of the +p100-LPP strain was problematic in the growth curve experiment. Therefore, the subsequent experimental strain was determined to be +p106-LPP, namely ΔycgF+LPP-OmpA-fimH.
[0108] 4. Crystal violet staining
[0109] To verify the biofilm formation capabilities of strain ΔycgF and the modified strain +p106-LPP, this example further performed a crystal violet staining experiment. The specific procedure is as follows: 200 μL of OD200 was added to each well of a 24-well plate. 600 =1 strain culture and 1800 μL LB liquid medium were incubated statically at 37°C for 30 h. The medium was then removed, and free cells were washed away with PBS buffer. The cells were fixed with 4% paraformaldehyde for 15 min, then the paraformaldehyde was removed. The biofilm was stained with 1% crystal violet dye, washed, dried, and dissolved in glacial acetic acid. Finally, the absorbance at 570 nm was read using a microplate reader.
[0110] The results are shown in Figure 7. From the figure, it can be seen that the OD of +p106-LPP... 570 The value is higher than ΔycgF, indicating a stronger biofilm formation ability.
[0111] Example 3: Preparation of mannose-modified carrier
[0112] Fiber materials (cotton fiber, flax, nylon, polyester, polypropylene fiber or polyethylene fiber) are placed in any one or more reagents containing polyethyleneimine, dopamine, and mannose (α-methyl-D-mannoside, D-mannose) to obtain mannose-modified fiber materials.
[0113] Taking cotton fiber (CF) as an example, cotton fiber material was added at a dosage of 20 g / L to 1000 mL of a modification solution composed of different dopamine, polyethyleneimine, and mannose (α-methyl-D-mannoside), using water as the solvent. The reaction time was 0.5–30 h, the reaction temperature was 20–80 °C, the rotation speed was 80–200 rpm, and the reaction pH was 3.5–10.5. After rinsing with pure water, the mixture was dried at 100 °C to constant weight, resulting in five mannose-modified cotton fiber carriers, as shown in Figure 8. Unmodified cotton fiber served as a control (0 in Figure 7).
[0114] The mass ratio of dopamine:polyethyleneimine:mannose is 0-1:0-2:0-40.
[0115] Specifically, in Erlenmeyer flasks No. 1 and No. 5, the mass ratio of dopamine, polyethyleneimine, and mannose is 1:1:10, and the order of solvent addition differs between the two flasks. In Erlenmeyer flask No. 1, polyethyleneimine is added first, followed by mannose, and finally dopamine; in Erlenmeyer flask No. 5, dopamine, polyethyleneimine, and mannose are added simultaneously.
[0116] Specifically, in Erlenmeyer flask No. 2, the mass ratio of dopamine:polyethyleneimine:mannose is 0:1:10.
[0117] Specifically, in Erlenmeyer flask No. 3, the mass ratio of dopamine, polyethyleneimine, and mannose is 1:1:0.
[0118] Specifically, in Erlenmeyer flask No. 4, the mass ratio of dopamine, polyethyleneimine, and mannose is 1:0:10.
[0119] The mannose-modified cotton fiber carrier in Erlenmeyer flask No. 2 in Figure 7 was selected for further research and analysis.
[0120] 1. Fourier Transform Infrared Spectroscopy (FITR)
[0121] At 4000cm -1 Up to 1000cm -1 The FTIR spectra of the modified cotton fiber carrier modified with mannose No. 2 were recorded within the range to analyze the characteristic functional groups on its surface.
[0122] The infrared spectrum results are shown in Figure 9. The mannose-modified cotton fiber carrier has an infrared spectrum at 3661 cm⁻¹. -1 The -NH2 vibration peak exists in polyethyleneimine, at 1640 cm⁻¹. -1 There is a C=N vibration peak at 890 cm⁻¹. -1 The presence of the -NH- vibration peak indicates successful modification of the cotton fiber carrier.
[0123] 2. HPLC determination of α-methyl-D-mannoside content on the support
[0124] The analysis of α-methyl-D-mannoside (α-D-Man) was performed at 60 °C using an Agilent 1260 Infinity II differential detector (RID) and an Aminex HPX-87H analytical high-performance liquid chromatography column with 5 mmol / L H2SO4 as the mobile phase and a flow rate of 0.4 mL / min.
[0125] The results showed that the amount of α-methyl-D-mannoside modified with the unmodified carrier was 0 mg / g, while the amount modified with the modified carrier was 165.5 mg / g. This indicates that α-methyl-D-mannoside was successfully modified onto the cotton fiber carrier during the modification process, with a modification amount reaching 165.5 mg / g carrier.
[0126] 3. Observation using a laser scanning confocal microscope (CLSM)
[0127] 200 μL of 50 μg / mL concanavalin A (excitation wavelength: 488 nm; emission wavelength: 505 nm) was added to both the modified and unmodified carriers. The mixture was stained at 4°C in the dark for 30 min. After washing away excess stain with PBS buffer, the mixture was dried at room temperature in the dark and mounted with anti-fluorescence attenuation mounting medium. The slides were then observed using a laser scanning confocal microscope (CLSM).
[0128] Figure 10 shows laser scanning confocal microscopy images of the carrier before and after modification, and of the carrier protein ConA after light-shielding staining. ConA specifically recognizes and binds to glycan chains containing sugar molecules such as α-D-mannose, α-D-glucose, and α-D-galactose. As can be seen from the figure, the modified carrier exhibits a significant ConA fluorescence signal compared to the unmodified carrier, indicating the presence of ConA on its surface. This demonstrates the successful introduction of mannose modification into the carrier surface, further confirming the successful application of the mannose-modified coating.
[0129] Example 4: Study on the adsorption performance of the target strain and carrier and its fermentation performance for producing L-threonine.
[0130] I. Carrier Processing
[0131] The original cotton fiber carrier (CF) was soaked in 1M NaOH for 1 hour, then rinsed with ultrapure water, soaked in 1M HCl solution for 1 hour, and then rinsed with sterile water to bring the pH to 7.0. It was then dried in an oven. The original cotton fiber carrier was modified according to the modification method in Example 3 to obtain a mannose-modified cotton fiber carrier (CF-Man). The carrier was cut into squares at a concentration of 30 g / L and inoculated into fermentation medium (formulation: 30 g / L glucose, 2 g / L yeast powder, 1 g / L KH2PO4, 22 g / L (NH4)2SO4, 0.8 g / L MgSO4·7H2O, 0.02 g / L MnSO4·5H2O, 0.02 g / L FeSO4·7H2O, 0.002 g / L vitamin B1, 30 g / L CaCO3). The medium was sterilized at 115°C for 20 minutes and then cooled.
[0132] II. Immobilized Continuous Fermentation
[0133] 1. Restore strain vitality
[0134] Take the bacterial culture tubes and place them in an ice box to thaw. After thawing, take appropriate amounts of ΔycgF and ΔycgF+LPP-OmpA-fimH strains and inoculate them into LB shakers. Incubate at 37°C to obtain bacterial cultures that have regained their viability.
[0135] 2. Collect the fermentation liquid
[0136] (1) Add 1 mL of the revitalized bacterial solution to each 100 mL shake flask and incubate at 37 °C for 12 h to obtain the seed solution.
[0137] (2) Pour 50 mL of fermentation medium into a 500 mL Erlenmeyer flask, take 2 mL of the seed liquid (i.e., 4% v / v inoculation amount) from step (1) and inoculate it into the Erlenmeyer flask, and add 100 mg / mL Amp resistance.
[0138] (3) The fermentation was carried out at a constant temperature of 37℃ and 200rpm in a shaker. The residual glucose and L-threonine production in the fermentation broth were measured every 6 hours. When the glucose content in the fermentation broth was lower than 1g / L, the first batch of fermentation was stopped. 80% of the fermentation broth was removed from the container, the carrier was retained, and an equal volume of sterile fermentation medium was added for the next batch of fermentation. The continuous fermentation was stopped when the L-threonine production stabilized.
[0139] 3. Determination of glucose content and L-threonine production
[0140] Every 6 hours, 2 mL of fermentation broth samples were centrifuged at 4°C and 12,000 rpm for 5 min. The supernatant was collected and its glucose content was determined using a saccharimeter.
[0141] The yield of L-threonine was determined by high-performance liquid chromatography (HPLC), and the parameters are shown in Table 5. The yield of L-threonine during immobilized continuous fermentation is shown in Table 6. Figure 11 shows the trend of various parameters during immobilized continuous fermentation of ΔycgF strain + CF (top of Figure 11) and ΔycgF + LPP-OmpA-fimH strain + CF-Man (bottom of Figure 11).
[0142] Table 5 Liquid Chromatography Parameters
[0143] Table 6 Immobilized Continuous Fermentation Data
[0144] 4. SEM electron microscopy imaging
[0145] The two types of carriers used in the immobilization and continuous fermentation process in step 3 were taken out and imaged using SEM. The carriers were washed three times with PBS, then fixed with 2.5% glutaraldehyde at 4°C for 12 hours, and then washed twice more with PBS. Next, they were dehydrated in a gradient using 0%, 50%, 70%, 80%, 90%, 95%, and 100% ethanol, with each concentration of ethanol used twice for 15 minutes each time. They were then soaked in tert-butanol for 10 minutes, centrifuged to remove the tert-butanol, and placed overnight at -80°C. Finally, the samples were freeze-dried using a vacuum freeze dryer and imaged using a Hitachi SU 8020 scanning electron microscope.
[0146] 5. Carrier elution
[0147] After immobilizing the two carriers in step 3 for continuous fermentation, wash away the free bacterial cells with PBS, and then add 30-50 mL of PBS buffer or PBS buffer containing mannoside to elute the E. coli on the carriers.
[0148] This embodiment utilizes the original strain ΔycgF for immobilized fermentation experiments on original cotton fiber carriers (CF) and modified cotton fiber carriers (CF-Man), and utilizes the recombinant strain ΔycgF+LPP-OmpA-fimH constructed in this invention for immobilized fermentation experiments on original cotton fiber carriers and modified cotton fibers. The fermentation results from seven batches of continuous immobilized fermentation experiments are shown in Table 6. As can be seen from the data in Table 6, the fermentation yield tended to stabilize at the fifth batch of continuous fermentation of ΔycgF strain + CF, and at the third batch of continuous fermentation of ΔycgF+LPP-OmpA-fimH strain + CF-Man. The yields of both ΔycgF strain + CF and ΔycgF+LPP-OmpA-fimH strain + CF-Man reached their highest values at the seventh batch, at 11.15 g / L and 13.62 g / L, respectively. As shown in Figure 11, the fermentation cycle of ΔycgF+LPP-OmpA-fimH + CF-Man was consistently shorter compared to ΔycgF + CF. The fermentation cycles for the last batches of ΔycgF + CF and ΔycgF+LPP-OmpA-fimH + CF-Man were 33 h and 28 h, respectively. Therefore, the immobilized yield of ΔycgF+LPP-OmpA-fimH + CF-Man was 22.15% higher than that of ΔycgF + CF, and the immobilized fermentation cycle of ΔycgF+LPP-OmpA-fimH + CF-Man was 15.15% shorter than that of ΔycgF + CF. The SEM images in Figure 12 show that ΔycgF+LPP-OmpA-fimH formed significantly more biofilm on mannose-modified cotton fibers than ΔycgF on unmodified cotton fibers. Figure 13 shows that the OD value of the supernatant after elution indicates that the buffer solution containing mannose can elute more E. coli.
[0149] In summary, the modified strain ΔycgF+LPP-OmpA-fimH exhibits stronger adsorption on cotton fibers compared to the original strain. The cotton fiber carrier, modified with mannosyl compounds, can adsorb more *E. coli*, with the ΔycgF+LPP-OmpA-fimH strain showing the best adsorption performance on CF+Man. Simultaneous modification of the strain and the medium promotes bacterial adhesion, significantly enhances *E. coli* biofilm formation, and improves the effectiveness of immobilized continuous fermentation.
[0150] This invention provides a method for the immobilized fermentation of L-threonine using recombinant Escherichia coli with surface-displayed adhesin proteins that specifically bind to modified materials. Many methods and approaches exist for implementing this technical solution; the above description is merely a preferred embodiment of the invention. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principles of this invention, and these improvements and modifications should also be considered within the scope of protection of this invention. All components not explicitly stated in this embodiment can be implemented using existing technologies.
Claims
1. A recombinant Escherichia coli, characterized in that, Using Escherichia coli ΔycgF as the starting strain, recombinant Escherichia coli with surface-displaying adhesin protein FimH was constructed by anchoring the adhesin protein with an anchoring protein. The anchoring protein includes any one of LPP-OmpA, Ag43, and eCPX.
2. The recombinant E. coli of claim 1, wherein, The nucleotide sequence of the adhesin protein FimH is shown in SEQ ID NO:4; the nucleotide sequence of the anchoring protein Lpp-OmpA is shown in SEQ ID NO:1; the nucleotide sequence of the anchoring protein Ag43 is shown in SEQ ID NO:2; and the nucleotide sequence of the anchoring protein eCPX is shown in SEQ ID NO:
3.
3. The recombinant E. coli of claim 1, wherein, The anchoring protein anchors the adhesin protein FimH to form a fusion protein, and the fusion protein is expressed by a promoter. The promoter is any one of the nucleotide sequences such as SEQ ID NO:5 to 9.
4. The application of the recombinant Escherichia coli according to any one of claims 1 to 3 in the immobilized fermentation production of L-threonine.
5. A method for immobilized fermentation of L-threonine, characterized by, Using modified fiber materials as carriers, L-threonine is produced by immobilized fermentation of recombinant Escherichia coli as described in any one of claims 1 to 322222222222222222.
6. The method of claim 5, wherein, The fiber material includes any one or a combination of several of the following: cotton fiber, flax, nylon, polyester, polypropylene fiber, and polyethylene fiber.
7. The method of claim 5, wherein, The modified fiber material is obtained by reacting the fiber material in a modification solution; The modified solution is wherein the solute is any one or a combination of several of polyethyleneimine, dopamine and mannose, and the solvent is water.
8. The method of claim 7, wherein, The mass ratio of dopamine, polyethyleneimine, and mannose is 0–1:0–2:0–40, and the ratio of the three components is not 0 at the same time.
9. The method of claim 7, wherein, The fiber material is added at a rate of 10–40 g / L.
10. The method of claim 5, wherein, The recombinant *E. coli* was inoculated with a seed culture at a rate of 2–8% v / v. The immobilized fermentation culture medium consisted of: 20–40 g / L glucose, 1–3 g / L yeast extract, 0.5–2 g / L KH₂PO₄, 20–30 g / L (NH₄)₂SO₄, 0.5–1 g / L MgSO₄·7H₂O, 0.01–0.05 g / L MnSO₄·5H₂O, 0.01–0.04 g / L FeSO₄·7H₂O, 0.001–0.003 g / L vitamin B1, and 10–30 g / L... CaCO3; The immobilized fermentation is carried out under the following conditions: constant temperature fermentation at 30-44℃ and 150-250rpm. When the glucose content in the fermentation broth is lower than 1g / L, the first batch of fermentation is ended, 60%-90% of the fermentation broth is discharged, and an equal volume of fermentation medium is added to carry out the second batch of fermentation. The immobilized fermentation process of discharging 60%-90% of the fermentation broth and adding an equal volume of fermentation medium is repeated for 5-8 batches.
